Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans

Cancer Causes and Control

Volumn 25, Issue 5, 2014, Pages 561-570

  Pibiri, Fabio ^a   Kittles, Rick A ^a   Sandler, Robert S ^b   Keku, Temitope O ^b   Kupfer, Sonia S ^c   Xicola, Rosa M ^a   Llor, Xavier ^a   Ellis, Nathan A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

African American population; Cancer health disparities; Colorectal cancer; Genetic risk factors; Vitamin D

Indexed keywords

CHOLESTANETRIOL 26 MONOOXYGENASE; CYTOCHROME P450 3A4; VITAMIN D; CYP2R1 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER INCIDENCE; COLORECTAL CANCER; CONTROLLED STUDY; CYP24A1 GENE; CYP27A1 GENE; CYP27B1 GENE; CYP2R1 GENE; CYP3A4 GENE; DHCR7 GENE; FEMALE; GC GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; HEALTH DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; VDR GENE; AGED; BLOOD; CASE CONTROL STUDY; COLORECTAL TUMOR; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; RISK FACTOR;

AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; CHOLESTANETRIOL 26-MONOOXYGENASE; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VITAMIN D;

EID: 84898864517     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0361-y     Document Type: Article

References (77)

1. Slominski A, Wortsman J (2000) Neuroendocrinology of the skin. Endocr Rev 21:457-487
2. Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503-511
3. Reis JP, von Mühlen D, Miller ER 3rd (2008) Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159:41-48 (Pubitemid 351969129)
4. Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S-1086S (Pubitemid 351549267)
5. Ascherio A, Munger KL, Simon KC (2010) Vitamin D and multiple sclerosis. Lancet Neurol 9:599-612
6. Hewison M (2011) Antibacterial effects of vitamin D. Nat Rev Endocrinol 7:337-345
7. Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9:227-231 (Pubitemid 11238851)
8. Liu N, Nguyen L, Chun RF et al (2008) Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149:4799-4808
9. Larriba MJ, Ordóñez-Morán P, Chicote I, Martín-Fernández G, Puig I, Muñoz A, Pálmer HG (2011) Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer. PLoS ONE 6:e23524
10. Hummel DM, Thiem U, Höbaus J et al (2012) Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis. J Steroid Biochem Mol Biol 136:284-288
11. Feskanich D, Ma J, Fuchs CS et al (2004) Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13:1502-1508 (Pubitemid 39202318)
12. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29:3775-3782
13. Wu K, Feskanich D, Fuchs CS et al (2011) Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS ONE 6:e28520
14. Hong SN, Kim JH, Choe WH et al (2012) Circulating vitamin D and colorectal adenoma in asymptomatic average-risk individuals who underwent first screening colonoscopy: a case-control study. Dig Dis Sci 57:753-763
15. Giovannucci E (2009) Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19:84-88
16. Hartman TJ, Albert PS, Snyder K et al (2005) Polyp Prevention Study Group. The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr 135:252-259 (Pubitemid 40194487)
17. Hubner RA, Muir KR, Liu JF, Logan RF, Grainge MJ, Houlston RS (2008) Members of UKCAP Consortium. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence. Int J Cancer 123:586-593 (Pubitemid 351898416)
18. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E (2008) Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17:2958-2969
19. Gorham ED, Garland CF, Garland FC et al (2007) Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32:210-216 (Pubitemid 46223622)
20. Garland CF, Gorham ED, Mohr SB, Garland FC (2009) Vitamin D for cancer prevention: global perspective. Ann Epidemiol 19:468-483
21. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2011) Meta-analysis: serum vitamin D and colorectal adenoma risk. Prev Med 53:10-16
22. Peterlik M, Cross HS (2006) Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res 26:2581-2588 (Pubitemid 44155538)
23. Kühn T, Kaaks R, Teucher B et al (2013) Dietary, lifestyle, and genetic determinants of vitamin D status: a cross-sectional analysis from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Eur J Nutr. doi: 10.1007/s00394-013-0577-8
24. Eelen G, Gysemans C, Verlinden L et al (2007) Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr Med Chem 14:1893-1910 (Pubitemid 47163407)
25. Carlberg C, Seuter S (2009) A genomic perspective on vitamin D signaling. Anticancer Res 29:3485-3493
26. American Cancer Society (2011) Colorectal cancer. Facts and figures 2011-2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-028323.pdf
27. Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Fifty years of cancer incidence: CI5 I-IX. Int J Cancer 127:2918-2927
28. Odelowo OO, Hoque M, Begum R, Islam KK, Smoot DT (2002) Colonoscopy for colorectal cancer screening in African Americans. J Assoc Acad Minor Phys 13:66-68
29. Murphy AB, Kelley B, Nyame YA et al (2012) Predictors of serum vitamin D levels in African American and European American men in Chicago. Am J Mens Health 6:420-426
30. Giovannucci E, Liu Y, Willett WC (2006) Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev 15:2467-2472 (Pubitemid 46048306)
31. Woolcott CG, Wilkens LR, Nomura AM, Horst RL, Goodman MT, Murphy SP, Henderson BE, Kolonel LN, Le Marchand L (2010) Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 19:130-134
32. Dong LM, Ulrich CM, Hsu L et al (2009) Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev 18:2540-2548
33. Poynter JN, Jacobs ET, Figueiredo JC et al (2010) Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 19:525-536
34. Protiva P, Cross HS, Hopkins ME et al (2009) Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev Res 2:43-51
35. Kupfer SS, Torres JB, Hooker S, Anderson JR, Skol AD, Ellis NA, Kittles RA (2009) Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. Carcinogenesis 30:1353-1357
36. Hiraki LT, Qu C, Hutter CM et al (2013) Genetic predictors of circulating 25-hydroxyvitamin D and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 22:2037-2046
37. Sansbury LB, Millikan RC, Schroeder JC et al (2006) COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States). Cancer Causes Control 17:257-266 (Pubitemid 43261889)
38. Kidd LC, Paltoo DN, Wang S et al (2005) Sequence variation within the 5′ regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk. Prostate 64:272-282 (Pubitemid 40980869)
39. Vinikoor LC, Long MD, Keku TO, Martin CF, Galanko JA, Sandler RS (2009) The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans. Cancer Epidemiol Biomarkers Prev 18:1239-1242
40. Wang TJ, Zhang F, Richards JB et al (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180-188
41. Ahn J, Yu K, Stolzenberg-Solomon R et al (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19:2739-2745
42. Robbins C, Torres JB, Hooker S et al (2007) Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 17:1717-1722 (Pubitemid 351359995)
43. Falush D, Stephens M, Pritchard JK (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164:1567-1587 (Pubitemid 37102217)
44. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337
45. Cross HS, Bareis P, Hofer H et al (2001) 25-Hydroxyvitamin D(3)-1 alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287-292 (Pubitemid 32140906)
46. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M (2001) Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86(2):888-894 (Pubitemid 32207511)
47. Bises G, Kállay E, Weiland T et al (2004) 25-hydroxyvitamin D3-1 alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52:985-989 (Pubitemid 38857163)
48. Gomme PT, Bertolini J (2004) Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 22:340-345 (Pubitemid 38887542)
49. Speeckaert M, Huang G, Delanghe JR, Taes YE (2006) Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372:33-42 (Pubitemid 44286753)
50. Nykjaer A, Dragun D, Walther D et al (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:507-515 (Pubitemid 29106838)
51. Chun RF (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30:445-456
52. Engelman CD, Fingerlin TE, Langefeld CD et al (2008) Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 93:3381-3388
53. Sinotte M, Diorio C, Berube S, Pollak M, Brisson J (2009) Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89:634-640
54. McCullough ML, Stevens VL, Diver WR et al (2007) Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 9:R9 (Pubitemid 350215152)
55. Abbas S, Linseisen J, Slanger T et al (2008) The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 17:1339-1343
56. Signorello LB, Shi J, Cai Q, Zheng W, Williams SM, Long J, Cohen SS, Li G, Hollis BW, Smith JR, Blot WJ (2011) Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D levels among African Americans. PLoS ONE 6:e28623
57. Holick MF (2013) Bioavailability of vitamin D and its metabolites in black and white adults. N Engl J Med 369:2047-2048
58. Powe CE, Evans MK, Wenger J et al (2103) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369:1991-2000
59. Jones G, Prosser DE, Kaufmann M (2012) 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys 523:9-18
60. McGrath JJ, Saha S, Burne TH, Eyles DW (2010) A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 121:471-477
61. Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, Galligan MA, Haussler MR, Jurutka PW (2013) CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res 73:2563-2573
62. Ghazi S, von Holst S, Picelli S et al (2010) Low-risk colorectal Cancer Study Group. Colorectal cancer susceptibility loci in a population-based study: associations with morphological parameters. Am J Pathol 177:2688-2693
63. Carethers JM (2011) One colon lumen but two organs. Gastroenterology 141:411-412
64. Mates IN, Jinga V, Csiki IE, Mates D, Dinu D, Constantin A, Jinga M (2012) Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage. J Gastrointestin Liver Dis 21:45-52
65. Macfarlane GT, Gibson GR, Cummings JH (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72:57-64
66. McBain AJ, Macfarlane GT (1998) Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol 47:407-416 (Pubitemid 28191044)
67. Lagergren J, Ye W, Ekbom A (2001) Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 121:542-547 (Pubitemid 32822568)
68. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N (2008) Is there a difference in survival between right-versus left-sided colon cancers? Ann Surg Oncol 15:2388-2394
69. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H (2010) Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53:57-64
70. Weiss JM, Pfau PR, O'Connor ES, King J, LoConte N, Kennedy G, Smith MA (2011) Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-medicare data. J Clin Oncol 29:4401-4409
71. Bhangu A, Kiran RP, Slesser A, Fitzgerald JE, Brown G, Tekkis P (2013) Survival after resection of colorectal cancer based on anatomical segment of involvement. Ann Surg Oncol 20:4161-4168
72. Phipps AI, Lindor NM, Jenkins MA, Baron JA, Win AK, Gallinger S, Gryfe R, Newcomb PA (2013) Colon and rectal cancer survival by tumor location and microsatellite instability: the colon cancer family registry. Dis Colon Rectum 56:937-944
73. Troisi RJ, Freedman AN, Devesa SS (1999) Incidence of colorectal carcinoma in the US: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 85:1670-1676 (Pubitemid 29169666)
74. Meggouh F, Lointier P, Pezet D, Saez S (1990) Evidence of 1,25-dihydroxyvitamin D3-receptors in human digestive mucosa and carcinoma tissue biopsies taken at different levels of the digestive tract, in 152 patients. J Steroid Biochem 36:143-147 (Pubitemid 20213578)
75. Kállay E, Adlercreutz H, Farhan H, Lechner D, Bajna E, Gerdenitsch W, Campbell M, Cross HS (2002) Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumor prevention and therapy. J Nutr 132:3490S-3493S (Pubitemid 35315825)
76. Suttie SA, Shaikh I, Mullen R, Amin AI, Daniel T, Yalamarthi S (2011) Outcome of right- and left-sided colonic and rectal cancer following surgical resection. Colorectal Dis 13:884-8849
77. Davis CD, Milner JA (2011) Vitamin D and colon cancer. Expert Rev Gastroenterol Hepatol 5:67-81